{
    "eid": "2-s2.0-84954399287",
    "title": "Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals",
    "cover-date": "2016-02-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Virology",
            "@code": "2406"
        }
    ],
    "keywords": [
        "Algorithm",
        "Drug resistance",
        "Subtype"
    ],
    "authors": [
        "Awachana Jiamsakul"
    ],
    "citedby-count": 5,
    "ref-count": 29,
    "ref-list": [
        "Statistician",
        "Global dispersal pattern of HIV type 1 subtype CRF01-AE: A genetic trace of human mobility related to heterosexual sexual activities centralized in southeast Asia",
        "Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update",
        "STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT",
        "Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific",
        "Global trends in molecular epidemiology of HIV-1 during 2000-2007",
        "Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis",
        "Update of the drug resistance mutations in HIV-1: March 2013",
        "Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance",
        "Web resources for HIV type 1 genotypic-resistance test interpretation",
        "Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain",
        "Increased Risk of Q151M and K65R Mutations in Patients Failing Stavudine-Containing First-Line Antiretroviral Therapy in Cambodia",
        "Development and performance of conventional HIV-1 phenotyping (Antivirogram\u00ae) and genotype-based calculated phenotyping assay (virco\u00aeTYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance",
        "A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand",
        "Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 Subtype CRF01_AE",
        "Human immunodeficiency virus reverse transcriptase and protease sequence database",
        "Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the swiss HIV cohort study",
        "Rationale and uses of a public HIV drug-resistance database",
        "Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent",
        "A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences",
        "Comparison of drug resistance scores for tipranavir in protease inhibitor-na\u00efve patients infected with HIV-1 B and non-B subtypes",
        "HIV-1 drug resistance mutations among antiretroviral-na\u00efve HIV-1-infected patients in Asia: Results from the TREAT Asia studies to evaluate resistance-monitoring study",
        "HIV-1 drug resistance mutations among antiretroviral-na\u00efve HIV-1-infected patients in Asia: Results from the TREAT Asia studies to evaluate resistance-monitoring study",
        "HIV-1 drug resistance at virological failure versus immunological failure among patients failing first-line antiretroviral therapy in a resource-limited setting",
        "HIV-1 antiretroviral resistance: Scientific principles and clinical applications",
        "A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype",
        "Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients",
        "Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling",
        "HIV-1 non-B subtypes: High transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability"
    ],
    "affiliation": [
        {
            "affiliation-city": "Manila",
            "affilname": "Research Institute for Tropical Medicine",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hong Kong",
            "affilname": "Queen Elizabeth Hospital Hong Kong",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "affilname": "University of Malaya Medical Centre",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Chiang Mai University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sungai Buloh",
            "affilname": "Hospital Sungai Buloh",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Chennai",
            "affilname": "VHS Medical Centre India",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Bali",
            "affilname": "Universitas Udayana",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Beerse",
            "affilname": "Janssen Pharmaceutica, Headquarters",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Kensington",
            "affilname": "The Kirby Institute",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kaohsiung",
            "affilname": "Kaohsiung Medical University",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Providence",
            "affilname": "Brown University",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "amfAR - The Foundation for AIDS Research",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kota Bharu",
            "affilname": "Hospital Raja Perempuan Zainab II",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Pune",
            "affilname": "Institute of Infectious Diseases",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Chiang Rai",
            "affilname": "Chiangrai Prachanukroh Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Institutes of Health",
        "National Institute of Allergy and Infectious Diseases",
        "National Institute of Allergy and Infectious Diseases"
    ]
}